CASI PHARMACEUTICALS, INC. (CASIF) Operating income 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual operating income history from SEC filings — each fiscal year as reported.
-$45.0MFY2025 · since FY2020: -$52.8M → -$45.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.0M | -13.6% |
| FY2024 | -$39.6M | -58.0% |
| FY2023 | -$25.1M | +26.3% |
| FY2022 | -$34.0M | +18.0% |
| FY2021 | -$41.5M | +21.3% |
| FY2020 | -$52.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice